Sentence examples for I trial at from inspiring English sources

The Bethesda woman is taking part in a phase I trial at the U.S. National Institutes of Health (NIH), one of several small studies getting under way in four countries to assess this vaccine's safety and the immune responses it triggers.

France's health ministry said that the six volunteers at the facility in Rennes, Brittany, had been in good health until taking the oral medication, which was manufactured by Portugal-based Biandlabeing being tested in a Phase I trial at the Biotrial clinic in the northwestern French city.

In 2006, a phase I trial at the Northwick Park Hospital, London, resulted in six volunteers suffering from life-threatening cytokine release syndrome [ 3].

Similar conclusions were reported in patients referred for a phase I trial at the MD Anderson Cancer Center who underwent a tumour biopsy of a metastasis to assess specific molecular alterations (Tsimberidou et al, 2012).

The effect of infusing the engineered T cells back into the cancer patients was tested in a Phase I trial at the University of Pennsylvania, and the initial results were described in two articles from the research team of Dr. Carl June.

70 We are currently addressing these questions by conducting a biopsy-mandated phase I/II trial at our centre, evaluating the efficacy of dovitinib in FGFR2-amplified and FGFR2-expressing gastric cancer samples.

In an SLV-I trial at nineteen elementary schools in California, coverage varied by school, with 26.9 %-46.6%-46.6%hindreachn each school receiving at least one dose of influenza vaccine with a large impact due to SLV-I; however in this setting control schools had virtually zero vaccination rates [ 47].

We analysed consecutive patients included in Phase-I trials at the Royal Marsden Hospital from 5 January 2005 to 6 June 2006.

For example, SLV-I trials at the state level in Hawaii and the three-county level in Minnesota resulted in very high vaccination rates of 46%% [ 25] and 41%% [ 46], respectively; however these were not clinical trials, no control schools existed, and the papers did not report what percent of vaccinations were delivered in school versus in physician offices.

This orally active compound is now being evaluated for phase I trials at Nereus Pharmaceuticals for the treatment of refractory multiple myeloma.

We performed this retrospective analysis in all patients who took part in phase I trials at the Drug Development Unit, Royal Marsden Hospital, over an 18-month period, from January 2005 to June 2006.